Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT06628076

Antibacterial Effect of Zinc Oxide Nanoparticles on Acinetobacter Baumannii Isolated From Patients With Hospital Acquired Infections in Sohag University Hospitals, Egypt

Conditions: Infections, Nosocomial, Infections, Respiratory Tract

Sex: All

Ages: N/A – 90 Years

Healthy volunteers: No

Enrollment: 150

Sponsor: Sohag University

Location: Sohag university, Faculty of medicine Sohag

Summary

A. baumannii is known as the most frequently isolated organism in intensive care units (ICUs), causing a variety of nosocomial infections, including pneumonia, urinary tract infections (UTIs), bacteremia as well as skin and soft tissue infections. These infections are usually associated with high mortality rates ranging between 26% among hospitalized patients and 43% among ICU patients.

Eligibility Criteria

Inclusion Criteria: * All patients suffering from infections that can be caused by A. baumannii. Exclusion Criteria: * All patients suffering from infections that aren\'t caused by A. baumannii.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06628076). StuddyBuddy aggregates publicly available trial information.